Followers | 43 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |
Friday, October 21, 2022 8:42:05 PM
“10:03a ET 8/12/2022 - Benzinga
Despite Strong Income And Revenue Growth LFTD Stock Plunges Following Earnings Release
LFTD Partners Inc. (OTCQB: LIFD) Q2 2022 revenue increased 151% to $16.8 million, up from $6.7 million in Q2 2021.
Q2 2022 Compared to Q2 2021:
Operating margin increased 3.14% to 26.40%, up from 23.25%
Net income increased 102% to $3.2 million up from $1.6 million- the eighth consecutive quarter of positive GAAP net income
Basic earnings per share ("EPS") increased 64% to $0.23 per share, up from $0.14
Diluted EPS up 82% to $0.20 per share, up from $0.11
Basic and diluted weighted average shares outstanding for the three months ended June 30, 2022 were 14.1 million and 15.9 million respectively
Balance Sheet Highlights - June 30, 2022 Compared to December 31, 2021:
Cash on hand increased 134% to $3.8 million up from $1.6 million
Inventory increased 164% to $10 million, up from $3.8 million
Current assets increased 50% to $19.7 million, up from $13.2 million
Current ratio increased to 2.09, from 1.10
Working capital increased 725% to $10.3 million, up from $1.2 million.
Nicholas S. Warrender, vice chairman and COO of LFTD Partners, and founder and CEO of Lifted Made, stated, "Q2 2022 was a record quarter for us in terms of net income, earnings per share, and free cash flow."
Price Action
LFTD Partners shares were trading 18.46% lower at $6.36 per share at the time of writing Friday morning.
Photo by Diyahna Lewis on Unsplash
Related News
LFTD Partners Prepays Its Remaining Secured Debt Of $916K
LFTD Partners Lowers Its Secured Debt, Here Are The Details
LFTD Partners Inc. Prepays One Third Of Total Secured Debt With Free Cash Flow From Subsidiary Company Lifted Made
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
my posts are always theory and not financial advice
Recent LIFD News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:15:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:06:45 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/21/2023 11:12:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2023 05:22:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 11:45:47 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 09:11:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 09:01:25 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM